Sino Biological FGFR4 Recombinant Mouse Protein (without Catalytic Activity Domain), His Tag
This recombinant protein was expressed from a DNA sequence encoding the extracellular domain (Met 1-Asp 366) of mouse FGFR4 (NP_032037.2) precursor fused to a polyhistidine tag at the C-terminus
Manufacturer: Invitrogen 50194M08H50
DescriptionFibroblast Growth Factor Receptor 4 (FGFR4), recombinant mouse protein is supplied as a lyophilized powder. It is suitable for use in analysis of protein structure, and performing cell based assays. It can also be used as an immunogen, as a protein standard, or in other research applications. Since this product is a truncated protein and does not contain intracellular catalytic activity domain, it is not suitable for use in enzyme activity studies.
- Activity: Measured by its ability to inhibit FGF acidic (aFGF/FGF1) dependent proliferation of Balb/c3T3 mouse embryonic fibroblasts; the ED50 for this effect is typically 55-75ng/mL
- Formulation: 140mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 7.4, 5% Mannitol, 5% Trehalose, 0.02% Tween 80
- Reconstitution: Dissolve the protein in sterile double distilled water to a concentration of 0.2mg/mL or lower; aliquot and use as soon as possible
|Proteins, Expression, Isolation & Analysis; Enzyme & Protein Activity Assays; Protein Assay Controls, Reference Standards & Accessories|
|≥85% by SDS-PAGE|
|Store at -5° to -30°C. Store aliquots under sterile conditions at -20°C. Avoid repeated freeze-thaw cycles. Expires one year from date of receipt when stored as instructed.|
|Fibroblast growth factor receptor 4|
|Fgfr-4, Fgfr4, Mpk-11|
|Growth Factors & Receptors|
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok